SUGAVIA-M 500
MRP: 2,025
Packaging: 10x15
Pack Type: tablet
Composition:
Sitagliptin 50mg + Metformin Hydrochloride IP 500mg
Indication:
As an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Description:
This tablet is a combination of Sitagliptin 50mg, a DPP-4 inhibitor, and Metformin Hydrochloride 500mg, a biguanide-class oral antidiabetic. It is used for the management of type 2 diabetes mellitus when diet, exercise, and monotherapy are not sufficient.
Sitagliptin enhances incretin levels, improving insulin secretion and reducing glucagon release.
Metformin reduces hepatic glucose production and improves insulin sensitivity in muscle cells.
Together, they provide a dual mechanism of action that effectively controls both fasting and postprandial blood glucose levels.
Tags:
- Controls both fasting and post-meal blood sugar
- Targets insulin secretion and resistance
- Low risk of hypoglycemia when used alone
- Weight neutral or modest weight loss
- Effective for long-term type 2 diabetes management
Usage Information
Dosage
Typically 1 tablet once or twice daily with meals Swallow whole with water Take at the same time daily for best results Do not exceed prescribed dose
Side Effects
Nausea, vomiting, diarrhea (commonly due to Metformin) Headache, sore throat, or upper respiratory tract infection (from Sitagliptin) Vitamin B12 deficiency (long-term Metformin use) Rare: pancreatitis, lactic acidosis
Contraindications
Type 1 diabetes or diabetic ketoacidosis Severe kidney or liver impairment History of lactic acidosis Alcohol abuse Known hypersensitivity to Sitagliptin or Metformin Pregnancy or breastfeeding (unless advised by a healthcare provider)
Availability
Sitagliptin Metformin 50/500, Sitagliptin 50mg, Metformin 500mg, type 2 diabetes combination tablet, oral hypoglycemic agent, blood sugar medicine